Document is current
Any future updates will be listed below
-
Authors
Cupelli, Michael
Ginjupalli, Vamsi Krishna Murthy
Reisqs, Jean-Baptiste https://orcid.org/0000-0001-9881-6670
Sleiman, Yvonne https://orcid.org/0000-0002-1550-8945
Becerra-Flores, Manuel
Accioli, Riccardo
Lazzerini, Pietro Enea
Cardozo, Timothy
Boutjdir, Mohamed
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (1R01HL164415)
Biomedical Laboratory Research and Development, VA Office of Research and Development (I01 BX002137)
U.S. Department of Defense (W81XWH-21-1-0424)
- License Information
-
More Information
Article History
Received: 19 February 2025
Accepted: 24 February 2026
First Online: 11 March 2026
Competing interests
: A patent application has been filed with the US Patent and Trademark Office for the hERG epitope mimic-decoy peptide, MDP4: Patent No.: US 11,787,840 B2; Date of Patent: Oct. 17, 2023; Title: Compositions and methods for treating and preventing autoimmune induced cardiac long QT syndrome; Inventors: Mohamed Boutjdir and Timothy Cardozo; Assignees: The United States Government as represented by the Department Of Veterans Affairs, Washington, DC (US); New York University, New York, NY (US). All other authors declare no competing interest.
